NASDAQ:OCUL

Ocular Therapeutix Stock Insider Trading

etoro logo Buy OCUL
*Your capital is at risk
$8.35
+0.0400 (+0.481%)
At Close: Jun 03, 2026

Ocular Therapeutix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 45.47. In total, the insiders bought 9.66M and sold 1.84M OCUL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
45.47
Buy 9.66M shares
Sell 1.84M shares
55% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Feb 12, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 45.47.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Oct 08, 2025
Sell
Common Stock
S-Sale
Anderman Todd
Chief Legal Officer
Officer 11 132
Value: $137.4K
Oct 08, 2025
Sell
Common Stock
S-Sale
Anderman Todd
Chief Legal Officer
Officer 11 132
Value: $137.4K
Oct 02, 2025
Sell
Common Stock
S-Sale
Kaiser Peter
Chief Development Officer
Officer 9 653
Value: $106.5K
Oct 02, 2025
Sell
Common Stock
S-Sale
Heier Jeffrey S.
Chief Scientific Officer
Officer 10 502
Value: $115.9K
Oct 02, 2025
Sell
Common Stock
S-Sale
Heier Jeffrey S.
Chief Scientific Officer
Officer 10 502
Value: $115.9K
Oct 02, 2025
Sell
Common Stock
S-Sale
Kaiser Peter
Chief Development Officer
Officer 9 653
Value: $106.5K
Sep 09, 2025
Sell
Common Stock
G-Gift
Dugel Pravin
See Remarks
Officer 49 754
Value: $0
Sep 09, 2025
Buy
Common Stock
G-Gift
Dugel Pravin
See Remarks
Officer 49 754
Value: $634.9K
Sep 09, 2025
Buy
Common Stock
G-Gift
Dugel Pravin
See Remarks
Officer 49 754
Value: $634.9K
Sep 09, 2025
Sell
Common Stock
G-Gift
Dugel Pravin
See Remarks
Officer 49 754
Value: $0
Sep 02, 2025
Sell
Common Stock
S-Sale
Notman Donald
See Remarks
Officer 1 066
Value: $13.3K
Sep 02, 2025
Sell
Common Stock
S-Sale
Notman Donald
See Remarks
Officer 1 066
Value: $13.3K
Aug 25, 2025
Sell
Common Stock
S-Sale
Kaiser Peter
Chief Development Officer
Officer 3 011
Value: $36.3K
Aug 25, 2025
Sell
Common Stock
S-Sale
Nayak Sanjay
Chief Strategy Officer
Officer 1 885
Value: $22.7K
Aug 25, 2025
Sell
Common Stock
S-Sale
Heier Jeffrey S.
Chief Scientific Officer
Officer 3 063
Value: $36.9K
Aug 25, 2025
Sell
Common Stock
S-Sale
Dugel Pravin
See Remarks
Officer 21 494
Value: $258.8K
Aug 25, 2025
Sell
Common Stock
S-Sale
Dugel Pravin
See Remarks
Officer 21 494
Value: $258.8K
Aug 25, 2025
Sell
Common Stock
S-Sale
Heier Jeffrey S.
Chief Scientific Officer
Officer 3 063
Value: $36.9K
Aug 25, 2025
Sell
Common Stock
S-Sale
Nayak Sanjay
Chief Strategy Officer
Officer 1 885
Value: $22.7K
Aug 25, 2025
Sell
Common Stock
S-Sale
Kaiser Peter
Chief Development Officer
Officer 3 011
Value: $36.3K
Aug 12, 2025
Buy
Common Stock
A-Award
Waheed Nadia
Chief Medical Officer
Officer 40 363
Value: $503.7K
Aug 12, 2025
Buy
Stock Option (Right to Buy)
A-Award
Waheed Nadia
Chief Medical Officer
Officer 122 923
Value: $1.53M
Aug 12, 2025
Buy
Stock Option (Right to Buy)
A-Award
Waheed Nadia
Chief Medical Officer
Officer 122 923
Value: $1.53M
Aug 12, 2025
Buy
Common Stock
A-Award
Waheed Nadia
Chief Medical Officer
Officer 40 363
Value: $503.7K
Aug 11, 2025
Buy
Common Stock
G-Gift
Dugel Pravin
See Remarks
Officer 250 361
Value: $3.14M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT OCULAR THERAPEUTIX
Ocular Therapeutix
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE